98%
921
2 minutes
20
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jtcvs.2025.03.031 | DOI Listing |
Catheter Cardiovasc Interv
September 2025
Department of Cardiology, University and Hospital Fribourg, Fribourg, Switzerland.
Background: Drug-coated balloon (DCB) angioplasty has emerged as a stentless alternative for de novo coronary artery disease. However, the prognostic value of post-procedural angiography-derived physiology, particularly three-dimensional (3D) Murray-law quantitative flow ratio (μQFR), after DCB in native vessels remains unclear.
Objectives: To quantify the prognostic value of immediate post-DCB 3D-μQFR for predicting lesion failure in de novo coronary disease.
Eur Heart J Open
September 2025
Division of Cardiovascular Medicine, Department of Internal Medicine, UT Southwestern Medical Center, 2001 Inwood Road Suite WC05.870, Dallas, TX 75390-9254, USA.
Aims: Patients with bicuspid aortic valve (BAV) stenosis were excluded from major TAVR trials, and data comparing TAVR and SAVR in this population remain limited. To compare real-world, risk-adjusted outcomes of TAVR vs. SAVR in patients with BAV stenosis.
View Article and Find Full Text PDFInt J Gen Med
August 2025
Center for Cardiovascular Diseases, Meizhou Academy of Medical Sciences, Meizhou People's Hospital, Meizhou, People's Republic of China.
Background: The renal safety and cardiovascular outcomes of intra-aortic balloon pump (IABP) support during percutaneous coronary intervention (PCI) in patients with renal dysfunction remain controversial.
Objective: To investigate the effects of IABP on renal function and major adverse cardiovascular events (MACEs) in PCI patients with renal dysfunction, and to establish an individualized prognostic prediction model.
Methods: In this retrospective cohort study, 253 PCI patients with renal dysfunction from Meizhou People's Hospital (January-December 2023) were analyzed.
Can J Cardiol
August 2025
Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada; Clinic Barcelona, Barcelona, Spain. Electronic address:
Background: Limited data are available on early hemodynamic outcomes of the balloon-expandable SAPIEN 3 Ultra Resilia (S3UR) from Edwards Lifesciences (Irvine, CA) compared with the self-expandable Evolut (Medtronic, Dublin, Ireland) transcatheter heart valves. In this study we aimed to compare the hemodynamic performance of the S3UR with contemporary Evolut platforms (Evolut PRO, PRO+, FX) in a propensity-matched study.
Methods: A total of 307 patients who received an S3UR valve were matched with 488 patients who received Evolut valves (mean age, 80.
PLoS Med
August 2025
Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
Background: Retrospective evidence indicated potential survival benefit of consolidative stereotactic radiotherapy (SRT) in patients with metastatic driver mutation-negative non-small cell lung cancer (NSCLC) harboring oligo-residual disease (ORD) after effective immune checkpoint inhibitor treatment. However, prospective data about consolidative SRT in this disease population after first-line chemoimmunotherapy remains scarce.
Methods And Findings: From March 2021 to March 2023, 59 patients (94.